Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 43, 2013 - Issue 6
138
Views
2
CrossRef citations to date
0
Altmetric
General Xenobiochemistry

Characterization of in vitro metabolites of luotonin A in human liver microsomes using electrospray/tandem mass spectrometry

, , , &
Pages 527-533 | Received 08 Oct 2012, Accepted 31 Oct 2012, Published online: 21 Dec 2012

References

  • Baldwin SJ, Bloomer JC, Smith GJ, Ayrton AD, Clarke SE, Chenery RJ. (1995). Ketoconazole and sulphaphenazole as the respective selective inhibitors of P4503A and 2C9. Xenobiotica 25:261–270.
  • Bowman WR, Elsegood MR, Stein T, Weaver GW. (2007). Radical reactions with 3H-quinazolin-4-ones: synthesis of deoxyvasicinone, mackinazolinone, luotonin A, rutaecarpine and tryptanthrin. Org Biomol Chem 5:103–113.
  • Cagir A, Jones SH, Gao R, Eisenhauer BM, Hecht SM. (2003). Luotonin A. A naturally occurring human DNA topoisomerase I poison. J Am Chem Soc 125:13628–13629.
  • Cagir A, Jones SH, Eisenhauer BM, Gao R, Hecht SM. (2004). Synthesis and biochemical properties of E-ring modified luotonin A derivatives. Bioorg Med Chem Lett 14:2051–2054.
  • Jahng KC, Kim SI, Kim DH, Seo CS, Son JK, Lee SH, Lee ES, Jahng Y. (2008). One-pot synthesis of simple alkaloids: 2,3-polymethylene-4(3H)-quinazolinones, luotonin A, tryptanthrin, and rutaecarpine. Chem Pharm Bull 56:607–609.
  • Kim KB, Seo KA, Yoon YJ, Bae MA, Cheon HG, Shin JG, Liu KH. (2008). In vitro metabolism of a novel PPAR gamma agonist, KR-62980, and its stereoisomer, KR-63198, in human liver microsomes and by recombinant cytochrome P450s. Xenobiotica 38:1165–1176.
  • Kunze KL, Trager WF. (1993). Isoform-selective mechanism-based inhibition of human cytochrome P450 1A2 by furafylline. Chem Res Toxicol 6:649–656.
  • Liang JL, Cha HC, Jahng Y. (2011). Recent advances in the studies on luotonins. Molecules 16:4861–4883.
  • Lee SK, Lee J, Lee ES, Jahng Y, Kim DH, Jeong TC. (2004). Characterization of in vitro metabolites of rutaecarpine in rat liver microsomes using liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom 18:1073–1080.
  • Ma Z, Hano Y, Nomura T, Chen Y. (2004). Novel quinazoline-quinoline alkaloids with cytotoxic and DNA topoisomerase II inhibitory activities. Bioorg Med Chem Lett 14:1193–1196.
  • Ma Z, Hano Y, Nomura T. (2005). Luotonin A: a lead toward anti-cancer agent development. Heterocycles 65:2203–2219.
  • Mussardo P, Corda E, González-Ruiz V, Rajesh J, Girotti S, Martín MA, Olives AI. (2011). Study of non-covalent interactions of luotonin A derivatives and the DNA minor groove as a first step in the study of their analytical potential as DNA probes. Anal Bioanal Chem 400:321–327.
  • Nacro K, Zha CC, Guzzo PR, Jason Herr R, Peace D, Friedrich TD. (2007). Synthesis and topoisomerase poisoning activity of A-ring and E-ring substituted luotonin A derivatives. Bioorg Med Chem 15:4237–4246.
  • Nordqvist M, Thakker DR, Vyas KP, Yagi H, Levin W, Ryan DE, Thomas PE, Conney AH, Jerina DM. (1981). Metabolism of chrysene and phenanthrene to bay-region diol epoxides by rat liver enzymes. Mol Pharmacol 19:168–178.
  • Tseng MC, Chu YW, Tsai HP, Lin CM, Hwang J, Chu YH. (2011). One-pot synthesis of luotonin A and its analogues. Org Lett 13:920–923.
  • Twin H, Batey RA. (2004). Intramolecular hetero Diels-Alder (Povarov) approach to the synthesis of the alkaloids luotonin A and camptothecin. Org Lett 6:4913–4916.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.